15 July 2020 : Clinical Research
Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome
Weiwen Liu1ABC*, Huihong Xu2DE, Xihui Ying1EFG, Dengke Zhang1CD, Linqiang Lai1BC, Linyou Wang3EF, Jianfei Tu1CFG, Jiansong Ji1BDGDOI: 10.12659/MSM.923263
Med Sci Monit 2020; 26:e923263
Table 3 The overall survival and progression free survival of the two group of patients.
| OS | PFS | |||
|---|---|---|---|---|
| TACE | TACE+RFA | TACE | TACE+RFA | |
| 1y | 48.1% | 76.2% | 11.9% | 43.2% |
| 2y | 19.5% | 57.9% | 1.3% | 31.1% |
| 3y | 6.5% | 37.1% | 0 | 18.0% |
| 4y | 1.3% | 21.5% | 0 | 12.6% |
| 5y | 0 | 16.4% | 0 | 9.5% |